Skip to main content

Helicobacter pylori

  • Reference work entry
  • First Online:
Glycoscience: Biology and Medicine

Abstract

Helicobacter pylori (H. pylori) is a microbe closely associated with pathogenesis of various gastric diseases, including chronic active gastritis and gastric cancer. Gastric gland mucin secreted from lower layer of the gastric mucosa characteristically contains O-glycans exhibiting terminal α1,4-linked GlcNAc residues (αGlcNAc). Cholesteryl-α-d-glucopyranoside (CGL) is a major component of the cell wall of Helicobacter species, including H. pylori, and is important for H. pylori survival. αGlcNAc suppresses CGL biosynthesis by inhibiting cholesterol α-glucosyltransferase (αCgT), which forms CGL; thus, αGlcNAc serves as a natural antibiotic against H. pylori infection in the stomach. Here, we summarize the protective functions of αGlcNAc against H. pylori and present an experimental protocol developed to test the effects of various glycans on H. pylori growth.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 899.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 549.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Hidaka E, Ota H, Hidaka H, Hayama M, Matsuzawa K, Akamatsu T, Nakayama J, Katsuyama T (2001) Helicobacter pylori and two ultrastructurally distinct layers of gastric mucous cell mucins in the surface mucous gel layer. Gut 49:474–480

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hirai Y, Haque M, Yoshida T, Yokota K, Yasuda T, Oguma K (1995) Unique cholesteryl glucosides in Helicobacter pylori: composition and structural analysis. J Bacteriol 177:5327–5333

    CAS  PubMed  PubMed Central  Google Scholar 

  • Hoshino H, Tsuchida A, Kametani K, Mori M, Nishizawa T, Suzuki T, Nakamura H, Lee H, Ito Y, Kobayashi M, Masumoto J, Fujita M, Fukuda M, Nakayama J (2011) Membrane-associated activation of cholesterol α-glucosyltransferase, an enzyme responsible for biosynthesis of cholesteryl-α-d-glucopyranoside in Helicobacter pylori critical for its survival. J Histochem Cytochem 59:98–105

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ilver D, Arnqvist A, Ogren J, Frick IM, Kersulyte D, Incecik ET, Berg DE, Covacci A, Engstrand L, Borén T (1998) Helicobacter pylori adhesin binding fucosylated histo-blood group antigens revealed by retagging. Science 279:373–377

    Article  CAS  PubMed  Google Scholar 

  • Ishihara K, Kurihara M, Goso Y, Urata T, Ota H, Katsuyama T, Hotta K (1996) Peripheral α-linked N-acetylglucosamine on the carbohydrate moiety of mucin derived from mammalian gastric gland mucous cells: epitope recognized by a newly characterized monoclonal antibody. Biochem J 318:409–416

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ito Y, Vela JL, Matsumura F, Hoshino H, Tyznik A, Lee H, Girardi E, Zajonc DM, Liddington KM, Bao X, Bugaytsova J, Borén T, Jin R, Zong Y, Seeberger PH, Nakayama J, Kronenberg M, Fukuda M (2013) Helicobacter pylori cholesteryl α-glucosides contribute to its pathogenicity and immune response by natural killer T cells. PLoS One 8:e78191

    Article  PubMed  PubMed Central  Google Scholar 

  • Kawakubo M, Ito Y, Okimura Y, Kobayashi M, Sakura K, Kasama S, Fukuda MN, Fukuda M, Katsuyama T, Nakayama J (2004) Natural antibiotic function of a human gastric mucin against Helicobacter pylori infection. Science 305:1003–1006

    Article  CAS  PubMed  Google Scholar 

  • Lee H, Kobayashi M, Wang P, Nakayama J, Seeberger PH, Fukuda M (2006) Expression cloning of cholesterol α-glucosyltransferase, a unique enzyme that can be inhibited by natural antibiotic gastric mucin O-glycans, from Helicobacter pylori. Biochem Biophys Res Commun 349:1235–1241

    Article  CAS  PubMed  Google Scholar 

  • Lee H, Wang P, Hoshino H, Ito Y, Kobayashi M, Nakayama J, Seeberger PH, Fukuda M (2008) α1,4GlcNAc-capped mucin-type O-glycan inhibits cholesterol α-glucosyltransferase from Helicobacter pylori and suppresses H. pylori growth. Glycobiology 18:549–558

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Warren JR, Marchall BJ (1983) Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet i:1273–1275

    Google Scholar 

Download references

Acknowledgments

We thank Dr. Elise Lamar for editing this manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jun Nakayama .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Japan

About this entry

Cite this entry

Kawakubo, M., Ito, Y., Fukuda, M., Nakayama, J. (2015). Helicobacter pylori . In: Taniguchi, N., Endo, T., Hart, G., Seeberger, P., Wong, CH. (eds) Glycoscience: Biology and Medicine. Springer, Tokyo. https://doi.org/10.1007/978-4-431-54841-6_145

Download citation

Publish with us

Policies and ethics